Andrew Chu
Podiatrist · Huntington Beach, CANPI 1538572243
Payments from drug & device makers
Across 156 payments — averaging $26.93 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pfizer$828
- Stryker$766
- Smith+Nephew$500
- Integra Lifesciences Corporation$362
- Zimmer Biomet$283
- Organogenesis Inc.$278
- plus $1K from 23 others
What the payments were for
- Food & beverage$4,201100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pfizer | 36 | $828 |
| Stryker(2 entities) | 18 | $766 |
| Smith+Nephew | 29 | $500 |
| Integra Lifesciences Corporation | 7 | $362 |
| Zimmer Biomet | 6 | $283 |
| Organogenesis Inc. | 8 | $278 |
| Nevro Corp. | 5 | $123 |
| Paratek Pharmaceuticals, Inc. | 6 | $115 |
| Paragon 28, Inc. | 1 | $101 |
| Polynovo North America LLC | 3 | $74 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 4 | $66 |
| Acera Surgical, Inc. | 1 | $62 |
| IBSA Pharma Inc. | 3 | $58 |
| Melinta Therapeutics, LLC | 3 | $56 |
| Reprise Biomedical, Inc. | 2 | $55 |
| Averitas Pharma Inc. | 2 | $54 |
| Inari Medical, Inc. | 2 | $51 |
| Mimedx Group, Inc. | 2 | $50 |
| Tactile Systems Technology Inc | 3 | $48 |
| Bioventus LLC | 2 | $48 |
| Alfasigma USA, Inc. | 2 | $40 |
| Amgen | 2 | $34 |
| Viiv Healthcare Company | 2 | $32 |
| Johnson & Johnson | 2 | $28 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $21 |
| Next Science LLC | 1 | $21 |
| Zyla Life Sciences, Inc. | 1 | $19 |
| TEI Medical Inc. | 1 | $15 |
| Saxum Surgical, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- INTEGRA$715
- EUCRISA$243
- INTEGRA DERMAL REGENERATION TEMPLATE$238
- PRIMATRIX$238
- AUGMENT INJECTABLE$169
- T2$169
- HOFFMANN$169
- Viaflow$160
- Lapidus Plate$149
- Foot and Ankle$103
How this compares
$4,201 in reported general payments places this provider in the 80th percentile of 721 podiatrist providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ammonium Lactate | 41 | $964 |
| Ciclopirox | 23 | $469 |
| Gabapentin | 56 | $246 |
| Doxycycline Hyclate | 21 | $109 |
| Methylprednisolone | 11 | $101 |
| Meloxicam | 32 | $100 |
Paid to pharmacies, not to this prescriber.
Other podiatrist in Huntington Beach
- Fardin HakakianTarzana$2.8M
- David GuzmanNapa$2.1M
- Shannon RushPleasanton$1.9M
- Babak BaravarianSanta Monica$1.6M
- David ArmstrongLos Angeles$1.4M
- Dean VayserCarlsbad$1.2M
- Robert KleimanCalexico$913K
- Bruce LawrenceOceanside$810K
- Shawn CazzellFresno$788K
- Philip WrotslavskyPoway$269K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.